227.81 1.18 (0.52%)
416.2K XNYS Volume
XNYS 17 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| L Majors Cary | SVP and President, Healthcare | Sale of securities on an exchange or to another person at price $ 217.32 per share. | 25 Nov 2024 | 1,682 | 11,372 (0%) | 0% | 217.3 | 365,532 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.78 per share. | 01 Oct 2024 | 194 | 42,736 (0%) | 0% | 235.8 | 45,741 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.78 per share. | 01 Oct 2024 | 91 | 33,251 (0%) | 0% | 235.8 | 21,456 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.78 per share. | 01 Oct 2024 | 130 | 56,186 (0%) | 0% | 235.8 | 30,651 | Ordinary Shares |
| Karen L. Burton | VP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.77 per share. | 01 Oct 2024 | 26 | 4,362 (0%) | 0% | 235.8 | 6,130 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.78 per share. | 01 Oct 2024 | 78 | 6,801 (0%) | 0% | 235.8 | 18,391 | Ordinary Shares |
| Julia K. Madsen | Sr. VP and GM, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.78 per share. | 01 Oct 2024 | 250 | 9,421 (0%) | 0% | 235.8 | 58,945 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 244.55 per share. | 13 Sep 2024 | 3,485 | 49,342 (0%) | 0% | 244.6 | 852,257 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 243.53 per share. | 13 Sep 2024 | 10,316 | 52,827 (0%) | 0% | 243.5 | 2,512,255 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.22 per share. | 13 Sep 2024 | 20,213 | 63,143 (0%) | 0% | 114.2 | 2,308,729 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 248.02 per share. | 13 Sep 2024 | 3,119 | 42,930 (0%) | 0% | 248.0 | 773,574 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.22 per share. | 13 Sep 2024 | 3,119 | 46,049 (0%) | 0% | 114.2 | 356,252 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 20,213 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 3,119 | 20,213 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 247.08 per share. | 13 Sep 2024 | 427 | 42,930 (0%) | 0% | 247.1 | 105,503 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 245.79 per share. | 13 Sep 2024 | 5,985 | 43,357 (0%) | 0% | 245.8 | 1,471,053 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 247.00 per share. | 10 Sep 2024 | 23,332 | 42,930 (0%) | 0% | 247 | 5,763,004 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 23,332 | 23,332 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 114.22 per share. | 10 Sep 2024 | 23,332 | 66,262 (0%) | 0% | 114.2 | 2,664,981 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 1,388 | 1,388 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 494 | 6,546 | - | - | Career Restricted Stock Units | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 442 | 6,988 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 95 | 6,151 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 2,197 | 2,197 | - | - | Director Stock Option (right to buy) | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 783 | 6,056 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 292 | 1,681 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 358 | 18,703 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 495 | 18,345 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 1,389 | 1,389 | - | - | Director Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 494 | 7,641 | - | - | Career Restricted Stock Units | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 1,388 | 1,388 | - | - | Director Stock Option (right to buy) | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 358 | 9,063 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 495 | 8,705 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 175 | 1,564 | - | - | Director Stock Option (right to buy) | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 1,389 | 1,389 | - | - | Director Stock Option (right to buy) | |
| Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 494 | 4,075 | - | - | Career Restricted Stock Units | |
| Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 1,388 | 1,388 | - | - | Director Stock Option (right to buy) | |
| Christopher S. Holland | Director | Grant, award, or other acquisition of securities at price $ 239.68 per share. | 08 Aug 2024 | 988 | 1,055 (0%) | 0% | 239.7 | 236,804 | Ordinary Shares |
| Christopher S. Holland | Director | Sale of securities on an exchange or to another person at price $ 239.68 per share. | 08 Aug 2024 | 473 | 582 (0%) | 0% | 239.7 | 113,369 | Ordinary Shares |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 494 | 6,016 | - | - | Career Restricted Stock Units | |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 1,388 | 1,388 | - | - | Director Stock Option (right to buy) | |
| Esther M. Alegria | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 988 | 2,409 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 782 | 6,055 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 417 | 6,472 | - | - | Career Restricted Stock Units | |
| Cary L Majors | SVP and President, Healthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.22 per share. | 05 Jun 2024 | 4,932 | 17,986 (0%) | 0% | 114.2 | 563,333 | Ordinary Shares |
| Cary L Majors | SVP and President, Healthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,932 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | SVP and President, Healthcare | Sale of securities on an exchange or to another person at price $ 229.63 per share. | 05 Jun 2024 | 4,932 | 13,054 (0%) | 0% | 229.6 | 1,132,535 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.07 per share. | 05 Jun 2024 | 3,252 | 12,923 (0%) | 0% | 77.1 | 250,632 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 05 Jun 2024 | 400 | 9,671 (0%) | 0% | 230 | 92,000 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 05 Jun 2024 | 400 | 10,071 (0%) | 0% | 69.7 | 27,888 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 3,252 | 0 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 400 | 0 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 05 Jun 2024 | 3,252 | 9,671 (0%) | 0% | 230 | 747,960 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 3,423 | 42,930 (0%) | 0% | 0 | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 21,720 | 21,720 | - | - | Employee Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 15,684 | 15,684 | - | - | Employee Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,128 | 33,342 (0%) | 0% | 0 | Ordinary Shares | |
| Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 12,849 | 56,316 (0%) | 0% | 0 | Ordinary Shares | |
| Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 81,544 | 81,544 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 3,144 | 3,144 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 918 | 4,388 (0%) | 0% | 0 | Ordinary Shares | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,264 | 2,264 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 663 | 6,879 (0%) | 0% | 0 | Ordinary Shares | |
| Cary L Majors | SVP and President, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 12,200 | 12,200 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | SVP and President, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,379 | 13,054 (0%) | 0% | 0 | Ordinary Shares | |
| Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,456 | 10,456 | - | - | Employee Stock Option (right to buy) | |
| Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,040 | 11,132 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,336 | 8,336 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,626 | 9,671 (0%) | 0% | 0 | Ordinary Shares | |
| Kenneth E. Kohler | SVP & GM, AST | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,900 | 7,900 | - | - | Employee Stock Option (right to buy) | |
| Kenneth E. Kohler | SVP & GM, AST | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,539 | 3,483 (0%) | 0% | 0 | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 506 | 39,507 (0%) | 0% | 228.4 | 115,555 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 771 | 40,013 (0%) | 0% | 228.4 | 176,073 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 1,100 | 40,784 (0%) | 0% | 228.4 | 251,207 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 253 | 29,214 (0%) | 0% | 228.4 | 57,778 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 225 | 29,712 (0%) | 0% | 228.4 | 51,383 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 245 | 29,467 (0%) | 0% | 228.4 | 55,951 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 680 | 44,530 (0%) | 0% | 228.4 | 155,292 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 1,063 | 43,467 (0%) | 0% | 228.4 | 242,757 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 480 | 45,210 (0%) | 0% | 228.4 | 109,618 | Ordinary Shares |
| Karen L. Burton | VP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 68 | 3,470 (0%) | 0% | 228.4 | 15,529 | Ordinary Shares |
| Karen L. Burton | VP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 60 | 3,597 (0%) | 0% | 228.4 | 13,702 | Ordinary Shares |
| Karen L. Burton | VP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 59 | 3,538 (0%) | 0% | 228.4 | 13,474 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 175 | 6,430 (0%) | 0% | 228.4 | 39,965 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.36 per share. | 03 Jun 2024 | 85 | 6,216 (0%) | 0% | 228.4 | 19,411 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 129 | 6,301 (0%) | 0% | 228.4 | 29,460 | Ordinary Shares |
| Cary L Majors | SVP and President, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 694 | 10,675 (0%) | 0% | 228.4 | 158,489 | Ordinary Shares |
| Mary Clare Fraser | SVP & Chief HRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 236 | 9,092 (0%) | 0% | 228.4 | 53,895 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.36 per share. | 03 Jun 2024 | 44 | 8,300 (0%) | 0% | 228.4 | 10,048 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 126 | 8,045 (0%) | 0% | 228.4 | 28,775 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 129 | 8,171 (0%) | 0% | 228.4 | 29,460 | Ordinary Shares |
| Kenneth E. Kohler | SVP & GM, AST | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.38 per share. | 03 Jun 2024 | 40 | 2,012 (0%) | 0% | 228.4 | 9,135 | Ordinary Shares |
| Kenneth E. Kohler | SVP & GM, AST | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 68 | 1,944 (0%) | 0% | 228.4 | 15,529 | Ordinary Shares |
| Kenneth E. Kohler | SVP & GM, AST | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.37 per share. | 03 Jun 2024 | 46 | 2,052 (0%) | 0% | 228.4 | 10,505 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 580 | 41,884 (0%) | 0% | 222.9 | 129,270 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 346 | 29,937 (0%) | 0% | 222.9 | 77,116 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 1,286 | 45,690 (0%) | 0% | 222.9 | 286,624 | Ordinary Shares |
| Karen L. Burton | VP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 102 | 3,657 (0%) | 0% | 222.9 | 22,734 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 72 | 6,605 (0%) | 0% | 222.9 | 16,047 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 207 | 8,344 (0%) | 0% | 222.9 | 46,136 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 124 | 6,347 (0%) | 0% | 222.9 | 27,637 | Ordinary Shares |
| Kenneth E. Kohler | SVP & GM, AST | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.88 per share. | 31 May 2024 | 112 | 2,098 (0%) | 0% | 222.9 | 24,963 | Ordinary Shares |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 4,584 | 0 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.53 per share. | 21 May 2024 | 4,584 | 32,554 (0%) | 0% | 51.5 | 236,214 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.22 per share. | 16 May 2024 | 1,154 | 7,831 (0%) | 0% | 114.2 | 131,810 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 1,154 | 0 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Sale of securities on an exchange or to another person at price $ 231.64 per share. | 16 May 2024 | 1,154 | 6,677 (0%) | 0% | 231.6 | 267,313 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.23 per share. | 15 May 2024 | 2,000 | 2,705 (0%) | 0% | 86.2 | 172,460 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,000 | 0 | - | - | Director Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Sale of securities on an exchange or to another person at price $ 237.65 per share. | 15 May 2024 | 2,000 | 705 (0%) | 0% | 237.7 | 475,300 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 235.84 per share. | 15 May 2024 | 17,500 | 48,644 (0%) | 0% | 235.8 | 4,127,200 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 234.54 per share. | 15 May 2024 | 3,281 | 66,144 (0%) | 0% | 234.5 | 769,526 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 233.34 per share. | 15 May 2024 | 5,039 | 69,425 (0%) | 0% | 233.3 | 1,175,800 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.07 per share. | 15 May 2024 | 32,000 | 74,464 (0%) | 0% | 77.1 | 2,466,240 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 32,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 236.22 per share. | 15 May 2024 | 6,180 | 42,464 (0%) | 0% | 236.2 | 1,459,840 | Ordinary Shares |
| Mohsen M. Sohi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 2,037 | 0 | - | - | Director Stock Option (right to buy) | |
| Mohsen M. Sohi | Director | Sale of securities on an exchange or to another person at price $ 234.04 per share. | 14 May 2024 | 1,438 | 22,361 (0%) | 0% | 234.0 | 336,550 | Ordinary Shares |
| Mohsen M. Sohi | Director | Sale of securities on an exchange or to another person at price $ 232.96 per share. | 14 May 2024 | 599 | 23,799 (0%) | 0% | 233.0 | 139,543 | Ordinary Shares |
| Mohsen M. Sohi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.53 per share. | 14 May 2024 | 2,037 | 24,398 (0%) | 0% | 51.5 | 104,967 | Ordinary Shares |
| Karen L. Burton | VP & CAO | Sale of securities on an exchange or to another person at price $ 235.95 per share. | 14 May 2024 | 3,000 | 3,759 (0%) | 0% | 236.0 | 707,850 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.53 per share. | 13 May 2024 | 4,584 | 4,584 (0%) | 0% | 51.5 | 236,214 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Sale of securities on an exchange or to another person at price $ 231.53 per share. | 13 May 2024 | 4,584 | 0 (0%) | 0% | 231.5 | 1,061,334 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 4,584 | 0 | - | - | Director Stock Option (right to buy) | |
| Cary L Majors | SVP and President, Healthcare | Sale of securities on an exchange or to another person at price $ 232.13 per share. | 13 May 2024 | 2,024 | 11,369 (0%) | 0% | 232.1 | 469,831 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2023 | 333 | 0 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.27 per share. | 04 Dec 2023 | 98 | 6,471 (0%) | 0% | 199.3 | 19,528 | Ordinary Shares |
| Xilas Andrew | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2023 | 333 | 6,569 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2023 | 605 | 333 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.81 per share. | 09 Oct 2023 | 178 | 6,236 (0%) | 0% | 225.8 | 40,194 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2023 | 605 | 6,414 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 215.51 per share. | 02 Oct 2023 | 61 | 30,283 (0%) | 0% | 215.5 | 13,146 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 215.50 per share. | 02 Oct 2023 | 130 | 46,976 (0%) | 0% | 215.5 | 28,015 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 215.50 per share. | 02 Oct 2023 | 26 | 6,759 (0%) | 0% | 215.5 | 5,603 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 215.50 per share. | 02 Oct 2023 | 171 | 8,551 (0%) | 0% | 215.5 | 36,851 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 215.51 per share. | 02 Oct 2023 | 85 | 5,809 (0%) | 0% | 215.5 | 18,318 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 525 | 5,688 | - | - | Career Restricted Stock Units | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 364 | 6,052 | - | - | Career Restricted Stock Units | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,544 | 1,544 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 261 | 1,805 | - | - | Director Stock Option (right to buy) | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 2,443 | 2,443 | - | - | Director Stock Option (right to buy) | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 279 | 5,273 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 831 | 4,994 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 364 | 17,850 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,544 | 1,544 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 326 | 1,870 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 525 | 17,486 | - | - | Career Restricted Stock Units | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,544 | 1,544 | - | - | Director Stock Options (right to buy) | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 525 | 7,147 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 364 | 8,210 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 525 | 7,846 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 195 | 1,740 | - | - | Director Stock Option (right to buy) | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,545 | 1,545 | - | - | Director Stock Option (right to buy) | |
| Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,050 | 3,581 | - | - | Career Restricted Stock Units | |
| Christopher S. Holland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 525 | 3,989 | - | - | Career Restricted Stock Units | |
| Christopher S. Holland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,544 | 1,544 | - | - | Director Stock Option (right to buy) | |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,544 | 1,544 | - | - | Director Stock Option (right to buy) | |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 525 | 5,522 | - | - | Career Restricted Stock Units | |
| Esther Alegria | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 1,050 | 1,421 | - | - | Career Restricted Stock Units | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.47 per share. | 02 Jun 2023 | 498 | 30,344 (0%) | 0% | 205.5 | 102,324 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.47 per share. | 02 Jun 2023 | 2,422 | 47,106 (0%) | 0% | 205.5 | 497,648 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.47 per share. | 02 Jun 2023 | 127 | 6,785 (0%) | 0% | 205.5 | 26,095 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.47 per share. | 02 Jun 2023 | 247 | 8,722 (0%) | 0% | 205.5 | 50,751 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.47 per share. | 02 Jun 2023 | 103 | 5,894 (0%) | 0% | 205.5 | 21,163 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.42 per share. | 01 Jun 2023 | 225 | 30,842 (0%) | 0% | 202.4 | 45,545 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.42 per share. | 01 Jun 2023 | 1,491 | 49,528 (0%) | 0% | 202.4 | 301,808 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.42 per share. | 01 Jun 2023 | 60 | 6,912 (0%) | 0% | 202.4 | 12,145 | Ordinary Shares |
| Mary Clare Fraser | SVP & Chief HRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.42 per share. | 01 Jun 2023 | 236 | 9,328 (0%) | 0% | 202.4 | 47,771 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.42 per share. | 01 Jun 2023 | 43 | 8,969 (0%) | 0% | 202.4 | 8,704 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 830 | 38,585 (0%) | 0% | 200.0 | 165,975 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 3,879 | 42,464 (0%) | 0% | 0 | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,964 | 26,964 | - | - | Employee Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 249 | 27,596 (0%) | 0% | 200.0 | 49,793 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 3,471 | 31,067 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 19,480 | 19,480 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 1,506 | 38,095 (0%) | 0% | 200.0 | 301,155 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,924 | 51,019 (0%) | 0% | 0 | Ordinary Shares | |
| Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 89,808 | 89,808 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 3,820 | 3,820 | - | - | Employee Stock Options (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 76 | 5,952 (0%) | 0% | 200.0 | 15,198 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,020 | 6,972 (0%) | 0% | 0 | Ordinary Shares | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,704 | 2,704 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 175 | 5,954 (0%) | 0% | 200.0 | 34,995 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 723 | 6,677 (0%) | 0% | 0 | Ordinary Shares | |
| Cary L Majors | SVP and President, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,697 | 13,393 (0%) | 0% | 0 | Ordinary Shares | |
| Cary L Majors | SVP and President, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 15,148 | 15,148 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | SVP and President, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 649 | 10,696 (0%) | 0% | 200.0 | 129,781 | Ordinary Shares |
| Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,984 | 12,984 | - | - | Employee Stock Option (right to buy) | |
| Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,313 | 9,564 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 9,740 | 9,740 | - | - | Employee Stock Options (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,734 | 9,012 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 199.97 per share. | 31 May 2023 | 32 | 7,278 (0%) | 0% | 200.0 | 6,399 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 7,172 | 7,172 | - | - | Employee Stock Option (right to buy) | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 1,278 | 5,997 (0%) | 0% | 0 | Ordinary Shares | |
| Esther Alegria | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 371 | 371 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 208.61 per share. | 16 May 2023 | 12,130 | 27,970 (0%) | 0% | 208.6 | 2,530,439 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Sale of securities on an exchange or to another person at price $ 209.67 per share. | 16 May 2023 | 931 | 705 (0%) | 0% | 209.7 | 195,203 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.23 per share. | 16 May 2023 | 2,058 | 2,763 (0%) | 0% | 86.2 | 177,461 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Sale of securities on an exchange or to another person at price $ 208.55 per share. | 16 May 2023 | 1,127 | 1,636 (0%) | 0% | 208.6 | 235,036 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 2,058 | 2,000 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 4,657 | 0 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Sale of securities on an exchange or to another person at price $ 212.56 per share. | 15 May 2023 | 4,657 | 0 (0%) | 0% | 212.6 | 989,892 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.92 per share. | 15 May 2023 | 4,657 | 4,657 (0%) | 0% | 43.9 | 204,535 | Ordinary Shares |
| Mohsen M. Sohi | Director | Sale of securities on an exchange or to another person at price $ 212.28 per share. | 15 May 2023 | 2,069 | 22,361 (0%) | 0% | 212.3 | 439,207 | Ordinary Shares |
| Mohsen M. Sohi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.92 per share. | 15 May 2023 | 2,069 | 24,430 (0%) | 0% | 43.9 | 90,870 | Ordinary Shares |
| Mohsen M. Sohi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,069 | 0 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 211.00 per share. | 15 May 2023 | 2,737 | 40,100 (0%) | 0% | 211 | 577,507 | Ordinary Shares |
| Cary L Majors | SVP and President, Healthcare | Sale of securities on an exchange or to another person at price $ 190.21 per share. | 03 Mar 2023 | 1,150 | 11,345 (0%) | 0% | 190.2 | 218,742 | Ordinary Shares |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.92 per share. | 15 Feb 2023 | 4,657 | 42,837 (0%) | 0% | 43.9 | 204,535 | Ordinary Shares |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,657 | 0 | - | - | Director Stock Option (right to buy) | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 333 | 938 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 191.91 per share. | 02 Dec 2022 | 98 | 4,719 (0%) | 0% | 191.9 | 18,807 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 333 | 4,817 (0%) | 0% | 0 | Ordinary Shares | |
| Cary L Majors | SVP and President, Healthcare | Sale of securities on an exchange or to another person at price $ 192.51 per share. | 01 Dec 2022 | 1,600 | 12,495 (0%) | 0% | 192.5 | 308,016 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.56 per share. | 10 Oct 2022 | 91 | 4,484 (0%) | 0% | 168.6 | 15,339 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 309 | 4,575 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.56 per share. | 10 Oct 2022 | 41 | 4,266 (0%) | 0% | 168.6 | 6,911 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 138 | 4,307 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 56 | 4,186 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.59 per share. | 10 Oct 2022 | 17 | 4,169 (0%) | 0% | 168.6 | 2,866 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 309 | 1,271 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 138 | 1,580 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2022 | 56 | 1,718 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.19 per share. | 07 Oct 2022 | 142 | 4,043 (0%) | 0% | 170.2 | 24,167 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 124 | 1,774 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 482 | 1,898 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.19 per share. | 07 Oct 2022 | 37 | 4,130 (0%) | 0% | 170.2 | 6,297 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 124 | 4,167 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 482 | 4,185 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.07 per share. | 03 Oct 2022 | 91 | 27,845 (0%) | 0% | 170.1 | 15,476 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.07 per share. | 03 Oct 2022 | 914 | 39,601 (0%) | 0% | 170.1 | 155,444 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.08 per share. | 03 Oct 2022 | 39 | 6,028 (0%) | 0% | 170.1 | 6,633 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.07 per share. | 03 Oct 2022 | 171 | 7,310 (0%) | 0% | 170.1 | 29,082 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.07 per share. | 03 Oct 2022 | 85 | 3,703 (0%) | 0% | 170.1 | 14,456 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 404 | 5,163 | - | - | Career Restricted Stock Units | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 573 | 4,759 | - | - | Career Restricted Stock Units | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 321 | 2,190 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,869 | 1,869 | - | - | Director Stock Option (right to buy) | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 842 | 4,163 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 2,743 | 2,743 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 401 | 2,270 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,869 | 1,869 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 404 | 16,961 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 573 | 16,557 | - | - | Career Restricted Stock Units | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,869 | 1,869 | - | - | Director Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 573 | 6,548 | - | - | Career Restricted Stock Units | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 74 | 6,622 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 241 | 2,110 | - | - | Director Stock Option (right to buy) | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,869 | 1,869 | - | - | Director Stock Option (right to buy) | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 573 | 7,321 | - | - | Career Restricted Stock Units | |
| Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,147 | 2,531 | - | - | Career Restricted Stock Units | |
| Christopher S. Holland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,147 | 3,464 | - | - | Career Restricted Stock Units | |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 573 | 4,997 | - | - | Career Restricted Stock Units | |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 1,869 | 1,869 | - | - | Director Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Sale of securities on an exchange or to another person at price $ 205.31 per share. | 15 Jun 2022 | 2,659 | 27,936 (0%) | 0% | 205.3 | 545,919 | Ordinary Shares |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.36 per share. | 02 Jun 2022 | 3,218 | 38,180 (0%) | 0% | 32.4 | 104,134 | Ordinary Shares |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,218 | 0 | - | - | Director Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 30,748 | 30,748 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 2,256 | 39,415 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.32 per share. | 02 Jun 2022 | 368 | 30,595 (0%) | 0% | 227.3 | 83,654 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 79,948 | 79,948 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 9,476 | 40,515 (0%) | 0% | 0 | Ordinary Shares | |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.32 per share. | 02 Jun 2022 | 88 | 6,067 (0%) | 0% | 227.3 | 20,004 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 2,560 | 2,560 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 564 | 6,129 (0%) | 0% | 0 | Ordinary Shares | |
| Cary L Majors | Sr VP Americas Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 9,736 | 9,736 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | Sr VP Americas Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 2,140 | 14,095 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.32 per share. | 02 Jun 2022 | 125 | 7,481 (0%) | 0% | 227.3 | 28,415 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 6,404 | 6,404 | - | - | Employee Stock Option (right to buy) | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 1,408 | 3,788 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,384 | 30,963 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 15,372 | 15,372 | - | - | Employee Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.46 per share. | 01 Jun 2022 | 675 | 27,579 (0%) | 0% | 221.5 | 149,486 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.46 per share. | 01 Jun 2022 | 178 | 5,255 (0%) | 0% | 221.5 | 39,420 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 900 | 6,155 (0%) | 0% | 0 | Ordinary Shares | |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 4,100 | 4,100 | - | - | Employee Stock option | |
| Mary Clare Fraser | SVP & Chief HRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.46 per share. | 01 Jun 2022 | 235 | 5,223 (0%) | 0% | 221.5 | 52,043 | Ordinary Shares |
| Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 9,224 | 9,224 | - | - | Employee Stock Option (right to buy) | |
| Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,028 | 7,251 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.45 per share. | 01 Jun 2022 | 42 | 6,198 (0%) | 0% | 221.5 | 9,301 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 6,404 | 6,404 | - | - | Employee Stock Options (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 1,408 | 7,606 (0%) | 0% | 0 | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.20 per share. | 31 May 2022 | 1,285 | 37,159 (0%) | 0% | 228.2 | 293,237 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.20 per share. | 31 May 2022 | 2,769 | 28,254 (0%) | 0% | 228.2 | 631,886 | Ordinary Shares |
| Daniel A. Carestio | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.20 per share. | 31 May 2022 | 810 | 31,039 (0%) | 0% | 228.2 | 184,842 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.20 per share. | 31 May 2022 | 942 | 5,433 (0%) | 0% | 228.2 | 214,964 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.20 per share. | 31 May 2022 | 151 | 5,565 (0%) | 0% | 228.2 | 34,458 | Ordinary Shares |
| Cary L Majors | Sr VP Americas Com Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.20 per share. | 31 May 2022 | 742 | 11,955 (0%) | 0% | 228.2 | 169,324 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.19 per share. | 31 May 2022 | 72 | 6,240 (0%) | 0% | 228.2 | 16,430 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Sale of securities on an exchange or to another person at price $ 255.48 per share. | 20 Apr 2022 | 8,000 | 31,023 (0%) | 0% | 255.5 | 2,043,876 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2022 | 8,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.98 per share. | 20 Apr 2022 | 8,000 | 39,023 (0%) | 0% | 68.0 | 543,840 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 07 Apr 2022 | 8,000 | 38,444 (0%) | 0% | 250 | 2,000,000 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 246.00 per share. | 29 Mar 2022 | 4,000 | 6,375 (0%) | 0% | 246 | 984,000 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2022 | 4,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.07 per share. | 29 Mar 2022 | 4,000 | 10,375 (0%) | 0% | 77.1 | 308,280 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 232.61 per share. | 15 Feb 2022 | 2,600 | 6,375 (0%) | 0% | 232.6 | 604,786 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,600 | 0 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 15 Feb 2022 | 2,600 | 8,975 (0%) | 0% | 69.7 | 181,272 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Sale of securities on an exchange or to another person at price $ 235.20 per share. | 10 Feb 2022 | 3,218 | 0 (0%) | 0% | 235.2 | 756,874 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 3,218 | 0 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.36 per share. | 10 Feb 2022 | 3,218 | 3,218 (0%) | 0% | 32.4 | 104,134 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 1,891 | 0 | - | - | Director Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.40 per share. | 10 Feb 2022 | 1,891 | 2,596 (0%) | 0% | 71.4 | 135,017 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Sale of securities on an exchange or to another person at price $ 234.10 per share. | 10 Feb 2022 | 1,891 | 705 (0%) | 0% | 234.1 | 442,683 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 30,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 240.00 per share. | 23 Dec 2021 | 30,000 | 46,444 (0%) | 0% | 240 | 7,200,000 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 23 Dec 2021 | 30,000 | 76,444 (0%) | 0% | 69.7 | 2,091,600 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 232.97 per share. | 15 Nov 2021 | 1,950 | 12,697 (0%) | 0% | 233.0 | 454,292 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.98 per share. | 22 Oct 2021 | 20,000 | 66,444 (0%) | 0% | 68.0 | 1,359,600 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2021 | 20,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 22 Oct 2021 | 20,000 | 46,444 (0%) | 0% | 235 | 4,700,000 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 506 | 2,713 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 11 Oct 2021 | 149 | 2,173 (0%) | 0% | 221.5 | 33,009 | Ordinary Shares |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 506 | 2,322 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2021 | 607 | 1,995 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2021 | 607 | 3,219 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.33 per share. | 07 Oct 2021 | 179 | 1,816 (0%) | 0% | 217.3 | 38,902 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 576 | 46,444 (0%) | 0% | 0 | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 9,460 | 9,460 | - | - | Employee Stock Option (rigt to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 808 | 31,023 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 8,196 | 8,196 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,156 | 31,849 (0%) | 0% | 0 | Ordinary Shares | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 18,920 | 18,920 | - | - | Employee Stock Options (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 344 | 6,375 (0%) | 0% | 0 | Ordinary Shares | |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,892 | 1,892 | - | - | Employee Stock Options (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 344 | 5,716 (0%) | 0% | 0 | Ordinary Shares | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,892 | 1,892 | - | - | Employee Stock Options (right to buy) | |
| Cary L Majors | Sr VP N America Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 3,784 | 3,784 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | Sr VP N America Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 692 | 14,647 (0%) | 0% | 0 | Ordinary Shares | |
| Mary Clare Fraser | Vice President & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 3,784 | 3,784 | - | - | Employee Stock Option (right to buy) | |
| Mary Clare Fraser | Vice President & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 692 | 5,458 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Sale or transfer of securities back to the company at price $ 228.36 per share. | 01 Oct 2021 | 121 | 6,312 (0%) | 0% | 228.4 | 27,632 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 3,152 | 3,152 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 576 | 6,433 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 6,304 | 6,304 | - | - | Employee Stock Options (right to buy) | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,156 | 1,388 (0%) | 0% | 0 | Ordinary Shares | |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 26 Aug 2021 | 149 | 5,521 (0%) | 0% | 69.7 | 10,388 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 1,000 | 436 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 300 | 0 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 149 | 0 | - | - | Employee Stock Option (right to buy) | |
| Renato Tamaro | V.P. & Corporate Treasurer | Sale of securities on an exchange or to another person at price $ 213.63 per share. | 26 Aug 2021 | 1,449 | 5,372 (0%) | 0% | 213.6 | 309,550 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.22 per share. | 26 Aug 2021 | 1,000 | 6,821 (0%) | 0% | 114.2 | 114,220 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.07 per share. | 26 Aug 2021 | 300 | 5,821 (0%) | 0% | 77.1 | 23,121 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 218.43 per share. | 13 Aug 2021 | 10,000 | 14,955 (0%) | 0% | 218.4 | 2,184,300 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2021 | 10,000 | 4,932 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 218.64 per share. | 13 Aug 2021 | 299 | 13,955 (0%) | 0% | 218.6 | 65,373 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 218.62 per share. | 13 Aug 2021 | 701 | 14,254 (0%) | 0% | 218.6 | 153,253 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2021 | 10,000 | 24,955 (0%) | 0% | 0 | Ordinary Shares | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 468 | 4,186 | - | - | Career Restricted Stock Units | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 2,027 | 2,027 | - | - | Director Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 508 | 3,718 | - | - | Career Restricted Stock Units | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 3,081 | 3,081 | - | - | Director Stock Option (right to buy) | |
| Mohsen M. Sohi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 751 | 3,321 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 471 | 2,498 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 2,027 | 2,027 | - | - | Director Stock Option (right to buy) | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 376 | 15,984 | - | - | Career Restricted Stock Units | |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 508 | 15,608 | - | - | Career Restricted Stock Units | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 2,054 | 2,054 | - | - | Director Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 500 | 5,975 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 500 | 6,748 | - | - | Career Restricted Stock Units | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 2,054 | 2,054 | - | - | Director Stock Option (right to buy) | |
| Richard Martin Steeves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 282 | 2,336 | - | - | Director Stock Option (right to buy) | |
| Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 1,001 | 1,384 | - | - | Career Restricted Stock Units | |
| Christopher S. Holland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 1,001 | 2,317 | - | - | Career Restricted Stock Units | |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 2,054 | 2,054 | - | - | Director Stock Option (right to buy) | |
| Nirav R. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.62 per share. | 10 Aug 2021 | 208 | 292 (0%) | 0% | 217.6 | 45,265 | Ordinary Shares |
| Nirav R. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 500 | 500 (0%) | 0% | 0 | Ordinary Shares | |
| David B. Lewis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2021 | 1,561 | 0 | - | - | Employee Stock Option (right to buy) | |
| David B. Lewis | Director | Grant, award, or other acquisition of securities at price $ 31.61 per share. | 21 Jul 2021 | 1,561 | 8,245 (0%) | 0% | 31.6 | 49,343 | Ordinary Shares |
| Richard C. Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 160 | 34,962 (0%) | 0% | - | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,292 | 45,868 (0%) | 0% | 0 | Ordinary Shares | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 36,296 | 36,296 | - | - | Employee Stock Option (right to buy) | |
| Paul E. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 383 | 383 | - | - | Career Restricted Stock Units | |
| Christopher S. Holland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 7 | 67 (0%) | 0% | - | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 3,276 | 30,215 (0%) | 0% | 0 | Ordinary Shares | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 17,284 | 17,284 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,056 | 30,693 (0%) | 0% | 0 | Ordinary Shares | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 59,316 | 59,316 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 4,148 | 4,148 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 784 | 6,031 (0%) | 0% | 0 | Ordinary Shares | |
| Renato Tamaro | V.P. & Corporate Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 576 | 5,372 (0%) | 0% | 0 | Ordinary Shares | |
| Renato Tamaro | V.P. & Corporate Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 3,040 | 3,040 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | Sr VP N America Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,368 | 10,368 | - | - | Employee Stock Option (right to buy) | |
| Cary L Majors | Sr VP N America Com Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 1,964 | 14,955 (0%) | 0% | 0 | Ordinary Shares | |
| Mary Clare Fraser | Vice President & Chief HRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 9,676 | 9,676 | - | - | Employee Stock Option (right to buy) | |
| Mary Clare Fraser | Vice President & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 1,836 | 4,766 (0%) | 0% | 0 | Ordinary Shares | |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2021 | 7,604 | 7,604 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 1,440 | 5,857 (0%) | 0% | 0 | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 1,445 | 2,421 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 999 | 3,420 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 277 | 976 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 232 | 232 (0%) | 0% | - | Ordinary Shares | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 113 | 3,533 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 373 | 3,906 | - | - | Restricted Stock Units | |
| Andrew Xilas | SVP and GM, Dental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 619 | 619 | - | - | Restricted Stock Units | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 1,946 | 43,576 (0%) | 0% | 188.4 | 366,685 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 1,945 | 26,939 (0%) | 0% | 188.4 | 366,496 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 1,677 | 24,637 (0%) | 0% | 188.4 | 315,997 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 897 | 5,247 (0%) | 0% | 188.4 | 169,022 | Ordinary Shares |
| Renato Tamaro | V.P. & Corporate Treasurer | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 133 | 4,796 (0%) | 0% | 188.4 | 25,061 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 2,129 | 12,991 (0%) | 0% | 188.4 | 401,167 | Ordinary Shares |
| Mary Clare Fraser | Vice President & Chief HRO | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 234 | 2,930 (0%) | 0% | 188.4 | 44,093 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 107 | 4,534 (0%) | 0% | 188.4 | 20,162 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale or transfer of securities back to the company at price $ 188.44 per share. | 01 Jun 2021 | 32 | 4,460 (0%) | 0% | 188.4 | 6,030 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale or transfer of securities back to the company at price $ 188.42 per share. | 01 Jun 2021 | 43 | 4,417 (0%) | 0% | 188.4 | 8,102 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale or transfer of securities back to the company at price $ 188.43 per share. | 01 Jun 2021 | 42 | 4,492 (0%) | 0% | 188.4 | 7,914 | Ordinary Shares |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 3,121 | 0 | - | - | Employee Stock Option (right to buy) | |
| Richard C. Breeden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.61 per share. | 27 May 2021 | 3,121 | 34,802 (0%) | 0% | 31.6 | 98,655 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.40 per share. | 25 May 2021 | 1,890 | 2,595 (0%) | 0% | 71.4 | 134,946 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 1,890 | 1,891 | - | - | Employee Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 2,110 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cynthia L. Feldmann | Director | Sale of securities on an exchange or to another person at price $ 190.84 per share. | 25 May 2021 | 1,890 | 705 (0%) | 0% | 190.8 | 360,688 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Sale of securities on an exchange or to another person at price $ 190.84 per share. | 25 May 2021 | 2,110 | 705 (0%) | 0% | 190.8 | 402,672 | Ordinary Shares |
| Cynthia L. Feldmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.05 per share. | 25 May 2021 | 2,110 | 2,815 (0%) | 0% | 64.1 | 135,146 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Sale of securities on an exchange or to another person at price $ 192.59 per share. | 21 May 2021 | 3,121 | 0 (0%) | 0% | 192.6 | 601,073 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2021 | 3,121 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jacqueline B. Kosecoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.61 per share. | 21 May 2021 | 3,121 | 3,121 (0%) | 0% | 31.6 | 98,655 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 215.00 per share. | 23 Apr 2021 | 1,000 | 4,641 (0%) | 0% | 215 | 215,000 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 1,000 | 400 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 23 Apr 2021 | 1,000 | 5,641 (0%) | 0% | 69.7 | 69,720 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 20 Apr 2021 | 1,000 | 4,641 (0%) | 0% | 210 | 210,000 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2021 | 1,000 | 1,400 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 20 Apr 2021 | 1,000 | 5,641 (0%) | 0% | 69.7 | 69,720 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 202.00 per share. | 08 Jan 2021 | 1,000 | 4,641 (0%) | 0% | 202 | 202,000 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 300 | 2,400 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 700 | 0 | - | - | Employee Stock Option (right to buy) | |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.15 per share. | 08 Jan 2021 | 700 | 5,341 (0%) | 0% | 66.2 | 46,305 | Ordinary Shares |
| Julia K. Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 08 Jan 2021 | 300 | 5,641 (0%) | 0% | 69.7 | 20,916 | Ordinary Shares |
| David B. Lewis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 1,560 | 1,561 | - | - | Employee Stock Option (right to buy) | |
| David B. Lewis | Director | Sale of securities on an exchange or to another person at price $ 193.79 per share. | 01 Dec 2020 | 1,560 | 6,684 (0%) | 0% | 193.8 | 302,312 | Ordinary Shares |
| David B. Lewis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.61 per share. | 01 Dec 2020 | 1,560 | 8,244 (0%) | 0% | 31.6 | 49,312 | Ordinary Shares |
| Jacqueline B. Kosecoff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2020 | 10,286 | 34,283 (0%) | 0% | 0 | Ordinary Shares | |
| Jacqueline B. Kosecoff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2020 | 7,644 | 26,639 (0%) | 0% | 0 | Ordinary Shares | |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 193.02 per share. | 09 Nov 2020 | 3,014 | 58,391 (0%) | 0% | 193.0 | 581,762 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 195.01 per share. | 09 Nov 2020 | 200 | 51,405 (0%) | 0% | 195.0 | 39,002 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 194.25 per share. | 09 Nov 2020 | 6,786 | 51,605 (0%) | 0% | 194.3 | 1,318,181 | Ordinary Shares |
| Julia Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 192.55 per share. | 09 Nov 2020 | 800 | 4,641 (0%) | 0% | 192.6 | 154,040 | Ordinary Shares |
| Julia Madsen | Senior VP, Life Sciences | Sale of securities on an exchange or to another person at price $ 192.36 per share. | 09 Nov 2020 | 1,100 | 5,441 (0%) | 0% | 192.4 | 211,596 | Ordinary Shares |
| Julia Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.52 per share. | 09 Nov 2020 | 800 | 6,541 (0%) | 0% | 53.5 | 42,816 | Ordinary Shares |
| Julia Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.34 per share. | 09 Nov 2020 | 1,100 | 5,741 (0%) | 0% | 45.3 | 49,874 | Ordinary Shares |
| Julia Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 800 | 0 | - | - | Employee Stock Option (right to buy) | |
| Julia Madsen | Senior VP, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 1,100 | 0 | - | - | Employee Stock Option (right to buy) | |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 180.60 per share. | 05 Nov 2020 | 2,337 | 69,068 (0%) | 0% | 180.6 | 422,062 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 182.19 per share. | 05 Nov 2020 | 1,300 | 61,405 (0%) | 0% | 182.2 | 236,847 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 181.52 per share. | 05 Nov 2020 | 6,363 | 62,705 (0%) | 0% | 181.5 | 1,155,012 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2020 | 4,897 | 71,405 (0%) | 0% | 0 | Ordinary Shares | |
| Karen L. Burton | VP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 179.38 per share. | 05 Nov 2020 | 2,852 | 7,894 (0%) | 0% | 179.4 | 511,592 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 2,852 | 0 | - | - | Employee Stock Option (right to buy) | |
| Karen L. Burton | VP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 179.48 per share. | 05 Nov 2020 | 1,750 | 6,144 (0%) | 0% | 179.5 | 314,090 | Ordinary Shares |
| Karen L. Burton | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 2,852 | 10,746 (0%) | 0% | 0 | Ordinary Shares | |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 05 Nov 2020 | 2,000 | 15,120 (0%) | 0% | 180 | 360,000 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 27,920 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 80 | 27,920 | - | - | Employee Stock Option (right to buy) | |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 189.00 per share. | 08 Oct 2020 | 6,243 | 45,522 (0%) | 0% | 189 | 1,179,927 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 188.24 per share. | 08 Oct 2020 | 15,677 | 51,765 (0%) | 0% | 188.2 | 2,951,038 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 187.17 per share. | 08 Oct 2020 | 6,000 | 67,442 (0%) | 0% | 187.2 | 1,123,020 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.52 per share. | 08 Oct 2020 | 27,920 | 73,442 (0%) | 0% | 53.5 | 1,494,278 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.52 per share. | 08 Oct 2020 | 80 | 45,602 (0%) | 0% | 53.5 | 4,282 | Ordinary Shares |
| Michael J. Tokich | Sr. Vice Pres., CFO | Sale of securities on an exchange or to another person at price $ 187.00 per share. | 08 Oct 2020 | 80 | 45,522 (0%) | 0% | 187 | 14,960 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 180.65 per share. | 06 Oct 2020 | 3,664 | 36,150 (0%) | 0% | 180.7 | 661,902 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 13,500 | 4,500 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 184.53 per share. | 06 Oct 2020 | 712 | 26,314 (0%) | 0% | 184.5 | 131,385 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 183.67 per share. | 06 Oct 2020 | 2,777 | 27,026 (0%) | 0% | 183.7 | 510,052 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 182.86 per share. | 06 Oct 2020 | 3,444 | 29,803 (0%) | 0% | 182.9 | 629,770 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 181.25 per share. | 06 Oct 2020 | 2,903 | 33,247 (0%) | 0% | 181.3 | 526,169 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.07 per share. | 06 Oct 2020 | 13,500 | 39,814 (0%) | 0% | 77.1 | 1,040,445 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.52 per share. | 01 Oct 2020 | 12,252 | 41,136 (0%) | 0% | 53.5 | 655,727 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 12,252 | 0 | - | - | Employee Stock Option (right to buy) | |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Sale of securities on an exchange or to another person at price $ 178.00 per share. | 01 Oct 2020 | 12,252 | 28,884 (0%) | 0% | 178 | 2,180,856 | Ordinary Shares |
| Julia Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 1,396 | 4,641 (0%) | 0% | 0 | Ordinary Shares | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2020 | 15,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 176.03 per share. | 18 Sep 2020 | 206 | 26,314 (0%) | 0% | 176.0 | 36,262 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 175.51 per share. | 18 Sep 2020 | 14,794 | 26,520 (0%) | 0% | 175.5 | 2,596,495 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 18 Sep 2020 | 15,000 | 41,314 (0%) | 0% | 69.7 | 1,045,800 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 168.94 per share. | 15 Sep 2020 | 1,039 | 33,275 (0%) | 0% | 168.9 | 175,529 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.98 per share. | 15 Sep 2020 | 8,000 | 34,314 (0%) | 0% | 68.0 | 543,840 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2020 | 8,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 170.31 per share. | 15 Sep 2020 | 211 | 26,314 (0%) | 0% | 170.3 | 35,935 | Ordinary Shares |
| Daniel A. Carestio | Sr VP and Chief Operating Off | Sale of securities on an exchange or to another person at price $ 169.66 per share. | 15 Sep 2020 | 6,750 | 26,525 (0%) | 0% | 169.7 | 1,145,205 | Ordinary Shares |
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 14 Sep 2020 | 2,000 | 28,884 (0%) | 0% | 167 | 334,000 | Ordinary Shares |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 153.33 per share. | 24 Aug 2020 | 4,307 | 48,188 (0%) | 0% | 153.3 | 660,392 | Ordinary Shares |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 154.94 per share. | 24 Aug 2020 | 506 | 27,242 (0%) | 0% | 154.9 | 78,400 | Ordinary Shares |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 154.36 per share. | 24 Aug 2020 | 19,494 | 27,748 (0%) | 0% | 154.4 | 3,009,094 | Ordinary Shares |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 154.32 per share. | 24 Aug 2020 | 946 | 47,242 (0%) | 0% | 154.3 | 145,987 | Ordinary Shares |
| Richard C. Breeden | Director | Sale of securities on an exchange or to another person at price $ 152.45 per share. | 24 Aug 2020 | 19,747 | 52,495 (0%) | 0% | 152.4 | 3,010,430 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.72 per share. | 10 Aug 2020 | 3,000 | 22,475 (0%) | 0% | 69.7 | 209,160 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 3,000 | 0 | - | - | Employee Stock Options (right to buy) | |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 155.88 per share. | 10 Aug 2020 | 218 | 0 (0%) | 0% | 155.9 | 33,982 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 155.62 per share. | 10 Aug 2020 | 2,355 | 17,120 (0%) | 0% | 155.6 | 366,485 | Ordinary Shares |
| Cary L Majors | Sr VP N America Com Operations | Sale of securities on an exchange or to another person at price $ 156.84 per share. | 10 Aug 2020 | 3,000 | 19,475 (0%) | 0% | 156.8 | 470,531 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 156.38 per share. | 06 Aug 2020 | 3,415 | 82,841 (0%) | 0% | 156.4 | 534,038 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 51,000 | 34,000 | - | - | Employee Stock Option (right to buy) | |
| Walter M. Rosebrough | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 51,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
| Walter M. Rosebrough | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 28,085 | 0 | - | - | Employee Stock Option (right to buy) | |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 156.79 per share. | 06 Aug 2020 | 709 | 76,302 (0%) | 0% | 156.8 | 111,164 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 155.79 per share. | 06 Aug 2020 | 5,874 | 77,011 (0%) | 0% | 155.8 | 915,110 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 155.03 per share. | 06 Aug 2020 | 9,799 | 82,885 (0%) | 0% | 155.0 | 1,519,139 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 154.05 per share. | 06 Aug 2020 | 11,552 | 92,684 (0%) | 0% | 154.1 | 1,779,586 | Ordinary Shares |
| Walter M. Rosebrough | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 152.91 per share. | 06 Aug 2020 | 23,066 | 104,236 (0%) | 0% | 152.9 | 3,527,022 | Ordinary Shares |